Circio Holding ASA (OSL:CRNA)

Market Cap	65.42M
Revenue (ttm)	n/a
Net Income (ttm)	57.52M
Shares Out	105.51M
EPS (ttm)	2.79
PE Ratio	0.22
Forward PE	0.97
Dividend	n/a
Ex-Dividend Date	n/a

Volume	39,204
Average Volume	250,718
Open	0.6140
Previous Close	0.6200
Day's Range	0.6140 - 0.6280
52-Week Range	0.4800 - 3.3100
Beta	1.53
RSI	45.28
Earnings Date	Aug 28, 2025

About HashiCorp

Circio Holding ASA, a biotechnology company, develops novel circular RNA and immunotherapy medicines. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. It has a collaboration with Certest Biotec, S.L. for formulation of circVec. The company was formerly known as Targovax ASA and changed its name to Circio Holdi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2010
• Employees: 10
• Stock Exchange: Oslo Børs
• Ticker Symbol: CRNA